ARTICLE | Clinical News
Arimoclomol regulatory update
May 9, 2005 7:00 AM UTC
FDA granted Orphan Drug designation to arimoclomol to treat amyotrophic lateral sclerosis (ALS). The hydroxylamine derivative was acquired from Biorex Research and Development Co. (Veszprem-Szabadsagp...